Top Markets
Coin of the day
SynBiotic SE SynBiotic SE

SynBiotic SE

SBX
Rank in Stocks #35084
SynBiotic SE is dedicated to pioneering cannabinoid-based pharmaceuticals and... SynBiotic SE is dedicated to pioneering cannabinoid-based pharmaceuticals and readily available health and wellness items. Its primary strategic pillars include the laboratory synthesis of cannabinoids, advanced drug discovery, the formulation of dietary aids, and the creation of cosmetic solutions. Formerly operating as Ledgertech SE, the company is headquartered in Munich, Germany.
Share Price
$0.94417952
Last synced: 2026-08-14
Market Cap
$4.48M
Change (1 day)
-23.90%
Change (1 year)
-74.31%
Country
DE
Trade SynBiotic SE (SBX)

Category

P/E ratio for SynBiotic SE (SBX)
P/E ratio as of 2026 TTM: 0
According to SynBiotic SE latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for SynBiotic SE from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.